Drug trial aims to curb blood loss in risky cancer surgeries
NCT ID NCT03128866
Summary
This early study is testing if a drug called tranexamic acid (TXA) can safely reduce blood loss during a major surgery to remove pelvic tumors. The surgery, called a hemipelvectomy, often involves significant bleeding. Researchers will compare blood loss and transfusion needs in about 80 patients who either receive TXA or undergo standard surgery without it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PELVIC MASS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.